Two Sigma Advisers’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Two Sigma Advisers’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,300	Closed	-$370K	–	877
2025 Q4	$370K	Buy	11,300 +2,600	+30%	+$83.9K	﹤0.01%	1901
2025 Q3	$301K	Buy	8,700 +1,200	+16%	+$38.4K	﹤0.01%	1986
2025 Q2	$210K	Sell	7,500 -36,000	-83%	-$965K	﹤0.01%	2101
2025 Q1	$1.09M	Buy	+43,500	New	+$1.1M	﹤0.01%	1435
2022 Q2	–	Sell	-7,800	Closed	-$484K	–	2732
2022 Q1	$484K	Sell	7,800 -6,600	-46%	-$404K	﹤0.01%	2002
2021 Q4	$794K	Sell	14,400 -700	-5%	-$36.5K	﹤0.01%	1686
2021 Q3	$794K	Buy	+15,100	New	+$896K	﹤0.01%	1723

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers's LKFT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026, closing a stake of 11,300 shares — an estimated $370K sold.

Two Sigma Advisers first reported a position in LKFT in Q3 2021 and held it in 7 quarters. The position peaked at $1.09M in Q1 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Two Sigma Advisers reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 11,300 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $370K.
Two Sigma Advisers first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2021 and held it in 7 quarters.
Two Sigma Advisers's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.09M in Q1 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.